课题基金 / 基金详情

项目摘要

项目成果

Ekaterina Heldwein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Herpes Simplex virus type 1 (HSV-1) requires four glycoproteins for cell entry and membrane fusion – gB, gD, gH, and gL – in addition to a cellular receptor. This number far exceeds the number of glycoproteins utilized by most other enveloped viruses complicating mechanistic studies of HSV-1-mediated entry and fusion. We now know that in HSV-1, as in other herpesviruses, the receptor-binding, regulatory, and fusogenic functions are distributed among several glycoproteins. gB is the conserved fusogen that, by analogy with other viral fusogens, is thought to facilitate membrane merger by undergoing large-scale refolding that brings the viral and cellular membranes together. However, gB is unusual in requiring several additional proteins for function. Therefore, understanding how gB works to mediate fusion during cell entry requires direct measurements of its fusogenic activity. Recently, single-particle tracking (SPT) has emerged as a powerful tool for quantitative studies of fusion of individual virions with fluid, supported lipid bilayers using total internal reflection microscopy. The SPT approach enables direct visualization and kinetic measurements of the viral fusion pathway and has been successfully used with both pH-triggered and receptor-triggered fusogens. The goal of this exploratory proposal is to develop single-particle imaging of HSV-1 fusion with supported lipid bilayers to visualize different stages in fusion, measure their kinetic parameters, identify kinetic intermediates, and correlate them with structural rearrangements in gB. Given that the SPT approach has not yet been applied to viruses that utilize >1 glycoprotein and may be challenging to apply to HSV-1 that has 15 envelope proteins, Aim 1 will utilize Vesicular Stomatitis Virus (VSV) virions lacking the native fusogen G and pseudotyped with HSV-1 entry glycoproteins gB, gD, gH, and gL (VSVDG-BHLD), which retain key characteristics of HSV-1 entry. In Aim 2, the SPT approach will be extended to HSV-1, a more complicated yet more biologically relevant system. The scientific premise of the proposed work is that harnessing the power of single-particle imaging of virion fusion provides a unique opportunity to address the lingering questions in HSV-mediated membrane fusion mechanism, with the ultimate goal of reconstructing the HSV-1-mediated fusion pathway more fully.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In-vitro analysis of HSV-1 membrane fusion mechanism
  • 批准号:
    10373110
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2021
  • 负责人:
    Ekaterina Heldwein
  • 依托单位:
Structure, antigenicity, and function of HCMV fusogen gB
  • 批准号:
    10315349
  • 项目类别:
  • 资助金额:
    $75.75万
  • 财政年份:
    2021
  • 负责人:
    Ekaterina Heldwein
  • 依托单位:
In-vitro analysis of HSV-1 membrane fusion mechanism
  • 批准号:
    10230779
  • 项目类别:
  • 资助金额:
    $25.48万
  • 财政年份:
    2021
  • 负责人:
    Ekaterina Heldwein
  • 依托单位:
Structure, antigenicity, and function of HCMV fusogen gB
  • 批准号:
    10651753
  • 项目类别:
  • 资助金额:
    $61.39万
  • 财政年份:
    2021
  • 负责人:
    Ekaterina Heldwein
  • 依托单位:
海外基金